These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 8020047)
21. Mechanisms by which K(ATP) channel openers produce acute and delayed cardioprotection. Wang Y; Haider HK; Ahmad N; Ashraf M Vascul Pharmacol; 2005; 42(5-6):253-64. PubMed ID: 15922258 [TBL] [Abstract][Full Text] [Related]
22. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart. Das B; Sarkar C J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767 [TBL] [Abstract][Full Text] [Related]
23. Evolving Issues in the Treatment of Angina Pectoris. Nicorandil: The 1st Potassium-Channel Activator in Ischemic Heart Disease. Proceedings of an International Workshop. Taormina, Sicily, May 8-12, 1991. J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S1-108. PubMed ID: 1282167 [No Abstract] [Full Text] [Related]
24. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts? Tosaki A; Szerdahelyi P; Engelman RM; Das DK J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798 [TBL] [Abstract][Full Text] [Related]
30. [Potassium agonists]. Hellwig B Med Monatsschr Pharm; 1994 Jun; 17(6):164-7. PubMed ID: 8052166 [No Abstract] [Full Text] [Related]
31. Effect of temperature on the activation of myocardial KATP channel in guinea pig ventricular myocytes: a pilot study by whole cell patch clamp recording. Jin SQ; Niu LJ; Deng CY; Yao ZB; Zhou YJ Chin Med J (Engl); 2006 Oct; 119(20):1721-6. PubMed ID: 17097020 [TBL] [Abstract][Full Text] [Related]
32. Potassium channels as pharmacological targets in cardiovascular medicine. Escande D; Henry P Eur Heart J; 1993 Jul; 14 Suppl B():2-9. PubMed ID: 8370367 [TBL] [Abstract][Full Text] [Related]
33. Electrophysiologic effects of potassium channel openers. Haverkamp W; Borggrefe M; Breithardt G Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():195-202. PubMed ID: 7647023 [TBL] [Abstract][Full Text] [Related]
34. NICORANDIL EFFICACY IN THE TREATMENT OF ISCHEMIC HEART DISEASE (REVIEW). Gvishiani M; Gabunia L; Makharadze T; Gongadze N Georgian Med News; 2018; (280-281):152-155. PubMed ID: 30204115 [TBL] [Abstract][Full Text] [Related]
35. Alterations in macrophage free radical and tumor necrosis factor production by a potassium channel activator. Pogrebniak HW; Matthews W; Pass HI J Surg Res; 1992 Apr; 52(4):395-400. PubMed ID: 1534387 [TBL] [Abstract][Full Text] [Related]